Guidance
Evidence-based recommendations on FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care.
Guidance development process
How we develop NICE diagnostics guidance
This guidance replaces NICE’s medtech innovation briefing on FibroScan for assessing liver fibrosis and cirrhosis in primary care (MIB216).